Immunodeficient NBSGW mouse strain allows chemotherapy modeling in AML patient‐derived xenografts

• Vilma Dembitz,
• Jozef Durko,
• Joana Campos,
• Sophie C. James,
• Hannah Lawson,
• Kamil R. Kranc,
• Paolo Gallipoli

Affiliations

Vilma Dembitz

Centre for Haemato‐Oncology, Barts Cancer Institute Queen Mary University of London London UK

Jozef Durko

Centre for Haemato‐Oncology, Barts Cancer Institute Queen Mary University of London London UK

Joana Campos

Centre for Haemato‐Oncology, Barts Cancer Institute Queen Mary University of London London UK

Sophie C. James

Centre for Haemato‐Oncology, Barts Cancer Institute Queen Mary University of London London UK

Hannah Lawson

Centre for Haemato‐Oncology, Barts Cancer Institute Queen Mary University of London London UK

Kamil R. Kranc

Centre for Haemato‐Oncology, Barts Cancer Institute Queen Mary University of London London UK

Paolo Gallipoli

Centre for Haemato‐Oncology, Barts Cancer Institute Queen Mary University of London London UK